• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Formulary
    • Exclusives
    • Top Companies
    • Raw Materials
    • End-User
    • Packaging
    • Directories
    • Events
    • Jobs
    • More
  • Magazine
  • News
  • Formulary
  • Exclusives
  • Top Companies
  • Raw Materials
  • End-User
  • Packaging
  • Directories
  • Events
  • Jobs
  • Current / Back Issues
    Features
    Columns
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    ACI Is Front & Center During the Pandemic

    Sun Care Market Set to Rebound in 2021 as Travel Returns

    Making Up for Lost Time

    All’s Well with Wellness

    Help for Indies
    Online Exclusives
    Association News
    Breaking News
    Financial News
    Industry News
    International
    Marketing News
    New Products
    News Front
    Packaging News
    Patents
    Personnel
    Regulations
    Snapshots
    Top News
    Live From Shows
    Top News
    Cococare Appoints First Woman President

    Ross Highlights Triple Shaft Mixers

    Arm & Hammer Unveils Foot Wipes

    Batiste Rolls Out Wonder Woman Dry Shampoo

    Erno Laszlo Taps Carina Lau as Global Spokesperson
    Blog
    Online Exclusives
    Infographics
    Podcasts
    Whitepapers
    Videos
    Expert's Opinion
    HappiTV
    eBook
    Surveys
    International Top 30 Report
    Top 50 Report
    Top Companies
    45. Atlantic Coast Brands

    18. Elizabeth Arden

    5. Shiseido

    12. Natura

    20. Rodan + Fields
    Actives
    Functional Ingredients
    Pigments
    Polymers
    Preservatives
    Surfactants

    American Crew Expands Hair Care Range

    The Fragrance Foundation Celebrates Fragrance Day

    China To End Animal Testing for Imported 'Ordinary' Cosmetics

    Inolex Appoints VP Marketing

    Croda International Acquires Alban Muller
    Air Care/Environmental Fragrance
    AP/Deo
    Color Cosmetics
    Disinfectants
    Fine Fragrance
    Hair Care
    Household Cleaning
    I&I Marketplace
    Laundry Care
    Oral Care
    OTC/Medicated
    Packaging
    Personal Cleansers
    Skin Care
    Sun Care
    Testing

    Cococare Appoints First Woman President

    Arm & Hammer Unveils Foot Wipes

    American Crew Expands Hair Care Range

    Erno Laszlo Taps Carina Lau as Global Spokesperson

    Guerlain Supports Women, Bees
    Lab Equipment
    Mixing
    Packaging
    Testing

    Ross Highlights Triple Shaft Mixers

    Sustainable Cosmetics Summit is Online in June

    A Tube Ready for Prime Time

    Ecovia's Sustainable Cleaning Products Summit Goes Online (March 23-25)

    Burt’s Bees Outlines New Sustainability Goals
    Contract Manufacturing / Private Label Directory
    Buyer's Guide
    Add New Company
    Corporate Profiles
    International Buyers Guide Companies
    Siltech Corporation

    Croda

    Praan Naturals

    LipoTrue Inc.

    BotanicalsPlus
    Live From Shows
    Meetings
    Webinars
    Snapshots
    • Magazine
      • Current / Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Formulary
    • Directories
      • Buyer's Guide
      • Contract Manufacturing / Private Label Directory
      • Corporate Profiles
      • Add Your Company
    • Raw Materials
      • Actives
      • Functional Ingredients
      • Pigments
      • Polymers
      • Preservatives
      • Surfactants
    • End-User
      • Air Care/Environmental Fragrance
      • AP/Deo
      • Color Cosmetics
      • Disinfectants
      • Fine Fragrance
      • Hair Care
      • Household Cleaning
      • I&I Marketplace
      • Laundry Care
      • Oral Care
      • OTC/Medicated
      • Packaging
      • Personal Cleansers
      • Skin Care
      • Sun Care
      • Testing
    • Packaging
      • Lab Equipment
      • Mixing
      • Packaging
      • Testing
    • Top Companies
      • International Top 30 Report
      • Top 50 Report
    • Online Exclusives
    • Experts Opinion
    • Slideshows
    • HappiTV
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Blog
    • Whitepapers
    • Surveys
      • R & D Salary Survey
      • Sales & Marketing Salary Survey
    • Job Banks
    • Events
      • Industry Events
      • Live from show Events
      • Webinars
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    CBD Safety Assessment

    A flood of all types of consumer products in the marketplace warrants a review of available scientific evidence.

    CBD Safety Assessment
    By Marilyn Barrett, PhD, Pharmacognosy Consulting, Inc., Mary Ellen Cosenza, PhD, MEC Regulatory & Toxicology Consulting, Steven Dentali, PhD, Dentali Botanical Sciences, and Sandy Bigelow, PhD, Vanguard Global Associates LLC04.10.20
    Significant public interest and consumer acceptance of cannabidiol (CBD) over the last 2-3 years has created a burgeoning marketplace with estimated sales last year of $5 billion. It cannot be denied that products purporting to contain CBD are pervasive.

    CBD is a terpenoid-phenolic compound, one of a class of compounds called cannabinoids that are produced in the resinous hairs (glandular trichomes) of Cannabis sativa L. The group of 20-plus major cannabinoids includes other cannabinoids such as Δ9-tetrahydrocannabinol (THC), its degradation product cannabinol, cannabigerol, cannabichromene and tetrahydrocannabivarin. THC produces psychogenic effects that may be associated with habitual use via regular cannabis smoking or ingestion of edibles. CBD has been found not to exert psychogenic effects and not to promote habitual use, thus exhibiting a limited potential for abuse.

    Regulatory Matters

    Until recently, all products made from cannabis were categorized as schedule I drugs, as per the Controlled Substances Act of 1970 (21 USC §801). Schedule I drugs are substances with no currently accepted medical use and a high potential for abuse. The Farm Bill enacted in December 2018 removed hemp from Schedule I controlled substances, making it an ordinary agricultural commodity. Hemp is defined as cannabis with not more than 0.3% of THC. The passage of the 2018 Farm Bill led many people to believe that CBD could be sold legally as a dietary supplement.

    In 1985, the Food and Drug Administration (FDA) approved two synthetic (not found in nature) cannabinoid-based drugs—dronabidol and nabilone—for use in a variety of indications including treatment of pain; they appear to be used as alternatives to opiates in relieving pain and for treating nausea in patients undergoing chemotherapy. In June of 2018, the FDA approved a CBD product, Epidiolex, to be marketed as a drug for the treatment of seizures associated with Lennox-Gastaut or Dravet syndromes in patients two years of age and older.

    Because CBD was first publicly investigated as a drug, the FDA concluded that it may not be legally sold as an ingredient in dietary supplements; the Dietary Supplement Health and Education Act (DSHEA) excludes such materials by definition. To further complicate the issue, individual states have passed their own laws pertaining to cannabis and CBD that contradict the federal position.

    Product Profiles

    This regulatory conundrum has not presented a roadblock to the explosion of sales of CBD products in the U.S. Numerous CBD-containing products are sold as foods, cosmetics and dietary supplements in the U.S. marketplace. Foods containing CBD include flavored waters and beer. Topical CBD products include creams, sprays and salves. Dietary supplement CBD products include tinctures, extracts and oils, capsules, pills and gummies. CBD is also often taken via inhalation by smoking cannabis and in vaping products. All of these products are taken by consumers with the hope of treatment for ailments such as joint pain, back pain, muscle soreness, headache, occasional sleeplessness, anxiety or stress. CBD products for pet use are also emerging in the marketplace.

    Some products contain purified CBD as an isolated compound, while others contain tinctures or extracts with CBD in a matrix of other compounds—either naturally present in the cannabis plant like other cannabinoids, terpenes and flavonoids, or additional ingredients not present in cannabis but thought to enhance the activity of CBD.

    Safety Analysis

    This escalation of products into the marketplace begs consideration of the question of consumer safety. Safety reviews of products in the public domain proceed in a systematic manner. In this process, the scientific literature is reviewed for indications of potential hazards. Highest priority is placed on adverse effects reported in humans, in descending order from clinical trials and observational studies, to case reports and anecdotal evidence. Toxicologists examine the literature to determine if a causal relationship to reported adverse events can be determined. They ask if the event was observed after the product was taken, how consistent this effect is, if there is a dose-related effect, and if the adverse event is biologically plausible according to biochemical and pharmacological information.

    Most toxicological evidence used in risk assessments come from animal studies. Doses much higher than consumed by humans are used to reveal any possible toxic responses in animals. Once results from these studies are gathered, considerations are made for possible species differences in metabolism and pharmacology between the animals and humans. Considerations are given to sensitive subpopulations that might have responses (in terms of incidence, severity or both) that are different from the responses expected for the healthy population.

    An important preliminary step in any safety evaluation is consideration of the absorption of the ingredient into the body. Factors that affect absorption and the ingredient’s action in the body include its concentration and chemical form, the nutrition and health of the individual, and the process of metabolizing and excreting the ingredient via urine and feces.

    Reports show that CBD is a fat-soluble compound that exhibits limited bioavailability (absorption from the gut into the body) after oral use. Oral ingestion of 20 mg CBD by humans leads to maximal plasma CBD levels within two hours of initial exposure and a plasma half-life of about two hours. Ingesting CBD with fatty foods delays absorption from the gastrointestinal tract, yet once absorbed leads to higher plasma levels.

    The literature identifies three possible areas of concern: the risk of liver damage, the risk of reproductive impairment and the potential for CBD-drug interactions. The first concern is derived from clinical findings with Epidiolex, which showed that oral CBD ingestion caused mild dose-dependent elevations in serum liver enzyme levels. Elevation of serum liver enzymes was also observed in several animal studies following intake of various preparations of CBD. However, these concerns did not meet the criteria for drug-induced liver toxicity as there was no concurrent elevation of blood levels of bilirubin, a reddish-yellow pigment made during the normal breakdown of hemoglobin in red blood cells. In other words, there was no evidence of jaundice and there was no change in blood coagulation. The identified risks for elevation of liver enzymes following intake of CBD were identified with higher doses, already elevated levels of these enzymes (liver dysfunction) and taking another seizure medication.

    The second concern from toxicological studies conducted in animals indicate potential detrimental effects on reproductive health as a decrease in sperm production in monkeys and mice. In contrast, the FDA review of studies conducted with Epidiolex concluded no effects on male or female rodent reproductive indices. However, the FDA is concerned about the lack of safety information on CBD regarding reproductive health and has released a caution against the use of CBD in supplements by pregnant or breastfeeding women. More studies are warranted, but as pregnant and breastfeeding women are especially sensitive, caution is advised.

    Lastly, there is a concern that CBD might alter the concentration levels of certain medicines in the body. CBD is reported to be a broad-spectrum but weak inhibitor of some enzymes in the liver (cytochrome P-450 enzymes) which might alter the way that other drugs are metabolized. So far, studies conducted in humans have only explored the combination of the drug Epidiolex with other anti-seizure medications. The significance of these findings to potential interactions between more common medicinal agents with CBD has not been determined clinically. Clinical studies in humans will need to be conducted to address this drug interaction potential more fully.

    In summary, the evidence suggests that healthy adults are unlikely to exhibit liver problems following CBD ingestion. However, it may be unwise for those with symptoms of liver disease to take CBD. Symptoms of liver disease can vary, but they often include swelling of the abdomen and legs, bruising easily, dark color stools and urine, and yellowing of the skin and eyes. It is prudent for those women and men planning on a pregnancy, and women who are pregnant or breastfeeding, to limit their CBD ingestion or avoid it altogether. Finally, those currently on medications should seek advice from their healthcare professional before taking CBD products. Consumers should also be mindful of CBD dosage and resist combining multiple sources of CBD in one day.
    Related Searches
    • cbd
    • approved
    • sales
    • consumers
    Related Knowledge Center
    • Functional Ingredients
    • Actives

    Related Features

    • Functional Ingredients | Laundry Care | Surfactants
      ACI Is Front & Center During the Pandemic

      ACI Is Front & Center During the Pandemic

      The American Cleaning Institute is working at the Federal, state and local levels to ensure the needs of its members and consumers are met during COVID-19.
      Tom Branna, Editorial Director 03.02.21

    • Actives | Polymers | Sun Care
      Sun Care Market Set to Rebound in 2021 as Travel Returns

      Sun Care Market Set to Rebound in 2021 as Travel Returns

      After a down year, will sun care market sales rebound in 2021 as consumers gear up to travel again and life slowly returns to normal?
      Christine Esposito, Managing Editor 03.02.21

    • Actives | Functional Ingredients | OTC/Medicated
      All’s Well with Wellness

      All’s Well with Wellness

      The pandemic has consumers focused on healthcare and wellness and that’s good news for some OTC categories.
      Tom Branna, Editorial Director 03.02.21


    • Functional Ingredients | Laundry Care | Polymers | Surfactants
      A Clean Commitment

      A Clean Commitment

      In a pandemic, clean matters more than ever; which explains the gains in fabric care sales. A list of new ingredients follows the article.
      Tom Branna, Editorial Director 01.06.21

    • Disinfectants | Functional Ingredients | Household Cleaning | Laundry Care
      Deliver & Delight

      Deliver & Delight

      The fragrances used in home cleaning products must communicate clean, but increasingly health and wellness, too.
      Christine Esposito, Managing Editor 01.06.21

    • Actives | Functional Ingredients | I&I Marketplace | Surfactants
      Front  & Center

      Front & Center

      The COVID-19 pandemic has moved commercial cleaning into the spotlight.
      Christine Esposito, Managing Editor 12.02.20


    • Functional Ingredients | Hair Care
      Clean-Label Shampoos with Xanthan Gum

      Clean-Label Shampoos with Xanthan Gum

      Thanks to its distinctive structure, xanthan gum provides a host of benefits when used as a thickener.
      Amirah Bajawi, Cameron Whitney and Dr. Teresa Berninger, Jungbunzlauer 12.02.20

    • Functional Ingredients | Hair Care | Polymers | Surfactants
      Just Hit Refresh

      Just Hit Refresh

      This year has been all about clean including advanced shampoo, conditioner and treatments for the scalp. A new ingredient list follows the article.
      Melissa Meisel , Associate Editor 12.02.20

    • Actives | OTC/Medicated | Skin Care
      Skin Care Actives  During  Inactivity

      Skin Care Actives During Inactivity

      When there’s nowhere to go, the focus is on the face.
      Tom Branna, Editorial Director 12.02.20


    • Fine Fragrance | Functional Ingredients
      This Stinks!

      This Stinks!

      The pandemic has been a plague on the fine fragrance industry; but the beauty industry is resilient and there are signs of a rebound.
      Tom Branna, Editorial Director 11.05.20

    • Actives | AP/Deo | Functional Ingredients | Personal Cleansers | Surfactants
      Me Time: The Market for Women

      Me Time: The Market for Women's Wellness

      While there is probably some slacking off due to social distancing, personal hygiene never goes out of style.
      Happi Staff 11.05.20

    • Actives | Personal Cleansers
      Lather Up for Long-Term Hand Hygiene for All

      Lather Up for Long-Term Hand Hygiene for All

      For Global Handwashing Day, October 15, several Henkel campaigns were aimed at improving compliance for everyone, but especially students.
      Martina Spinatsch, Henkel North America 11.05.20


    • Actives | Skin Care

      Rice-Derived Lactic Acid Bacteria Improves Skin Flora and Barrier

      Ichimaru Pharcos researchers detail the benefits of Fairy Flora K-1, which boosts the beneficial skin bacteria Coagulase-negative staphylococci.
      Kentaro Hirose and Arunasiri Iddamalgoda PhD , Ichimaru Pharcos Co.Ltd. 11.05.20

    • Actives | Skin Care

      Keys to Nourishing CBD Skin Care Growth

      Improving ingredient delivery through carrier oils can go a long way to meeting consumer demand for product performance.
      John Toner & Diva Chan, Aprinnova 11.02.20

    • Actives | Functional Ingredients
      A Reliable Path to Working with CBD in the U.S.

      A Reliable Path to Working with CBD in the U.S.

      The future of U.S. hemp is bright, but it will take time for the industry to mature following years of regulatory restrictions.
      Brian Zapp, Creative Director, Applied Food Sciences 11.02.20

    Trending
    • Sunscreen On The Spot
    • L'Oréal Appoints Two To Executive Committee
    • BASF Achieves Palm Oil Commitment For 2020
    • Avon Launches Vegan Skin Care Line
    • Formulating Liquid Laundry Detergents
    Breaking News
    • Cococare Appoints First Woman President
    • Ross Highlights Triple Shaft Mixers
    • Arm & Hammer Unveils Foot Wipes
    • Batiste Rolls Out Wonder Woman Dry Shampoo
    • Erno Laszlo Taps Carina Lau as Global Spokesperson
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • ACI Is Front & Center During the Pandemic
    • Rise… Then Shine
    • Making Up for Lost Time
    • All’s Well with Wellness
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Diets High In Fructose Could Cause Immune System Damage
    Nestlé Acquires Premium Water Brand Essentia
    Kaneka Probiotics Announces Launch of L. plantarum DR7
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President, COO
    Ashland Completes Expansion, Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcoVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs First OTC Home Molecular COVID-19 Test
    FDA Approves Second Sight's Argus 2s Retinal Prosthesis
    Cross Border Venture Financing Rose in Final Quarter of 2020
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sharp Appoints EU Qualified Person
    Baxter Biopharma Solutions Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine
    Metrics Contract Services Completes Russian Regulatory Inspection
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    It's International Women's Day—But What Does That Mean?
    e.l.f. Cosmetics and Chipotle Collaborate on Burrito-Inspired Makeup Collection
    Weekly Recap: Sephora Expansion, Ulta Partners with Loop, International Women’s Day & More
    Happi

    Latest Breaking News From Happi

    Cococare Appoints First Woman President
    Ross Highlights Triple Shaft Mixers
    Arm & Hammer Unveils Foot Wipes
    Ink World

    Latest Breaking News From Ink World

    Capital Printing Invests in 2nd Komori Press
    Arna Marketing Adds Canon’s ProStream, VarioPRINT iX Production Inkjet Presses
    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Xeikon details upcoming Xeikon Café TV seminars
    Resource Label Group acquires New England Label
    UV+EB-cured products rated 'easier to recycle'
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Arm & Hammer Launches Foot Wipes
    Kimberly-Clark Names Chief Research and Development Officer
    FPInnovations Develops Biodegradable Mask
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Australia Clears Conformis' iTotal PS Knee Replacement System
    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research
    Wearable Patch Market to Reach $27.8 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login